| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RNA | Common Stock | Options Exercise | $49,600 | +40,000 | +3008% | $1.24* | 41,330 | 29 Dec 2022 | Direct | F1 |
| transaction | RNA | Common Stock | Sale | $880,568 | -40,000 | -97% | $22.01 | 1,330 | 29 Dec 2022 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RNA | Stock Option (Right to Buy) | Options Exercise | $0 | -40,000 | -31% | $0.000000 | 88,423 | 29 Dec 2022 | Common Stock | 40,000 | $1.24 | Direct | F1, F3 |
| Id | Content |
|---|---|
| F1 | The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. |
| F2 | The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $22.00 to $22.16. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F3 | 25% of the shares subject to the option vested on February 19, 2021, and 1/48th of the shares subject to the option will vest monthly thereafter. |